Infinimmune
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
$75MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease
Miniaturizes gene editing workflows to enable direct edits on primary patient cells for cell therapy and drug discovery
Pitching Merck Global Health Innovation Fund? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room